670 related articles for article (PubMed ID: 19485785)
1. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK
Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785
[TBL] [Abstract][Full Text] [Related]
2. Successful Nonsurgical Eradication of Invasive Gastric Mucormycosis.
El Hachem G; Chamseddine N; Saidy G; Choueiry C; Afif C
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S145-8. PubMed ID: 27521312
[No Abstract] [Full Text] [Related]
3. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Riley TT; Muzny CA; Swiatlo E; Legendre DP
Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia.
Rickerts V; Atta J; Herrmann S; Jacobi V; Lambrecht E; Bialek R; Just-Nübling G
Mycoses; 2006; 49 Suppl 1():27-30. PubMed ID: 16961579
[TBL] [Abstract][Full Text] [Related]
5. Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.
Ville S; Talarmin JP; Gaultier-Lintia A; Bouquié R; Sagan C; Le Pape P; Giral M; Morio F
Exp Clin Transplant; 2016 Feb; 14(1):96-9. PubMed ID: 25275881
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy.
Almannai M; Imran H; Estrada B; Siddiqui AH
Pediatr Hematol Oncol; 2013 Apr; 30(3):184-6. PubMed ID: 23444832
[TBL] [Abstract][Full Text] [Related]
7. Mucormycosis treated with posaconazole: review of 96 case reports.
Vehreschild JJ; Birtel A; Vehreschild MJ; Liss B; Farowski F; Kochanek M; Sieniawski M; Steinbach A; Wahlers K; Fätkenheuer G; Cornely OA
Crit Rev Microbiol; 2013 Aug; 39(3):310-24. PubMed ID: 22917084
[TBL] [Abstract][Full Text] [Related]
8. [Mucormycosis: therapeutic news].
Pilmis B; Lanternier F; Lortholary O
Med Sci (Paris); 2013 Mar; 29 Spec No 1():25-30. PubMed ID: 23510522
[TBL] [Abstract][Full Text] [Related]
9. A mucormycosis case in a cirrhotic patient successfully treated with posaconazole and review of published literature.
Lin SY; Lu PL; Tsai KB; Lin CY; Lin WR; Chen TC; Chang YT; Huang CH; Chen CY; Lai CC; Chen YH
Mycopathologia; 2012 Dec; 174(5-6):499-504. PubMed ID: 22744722
[TBL] [Abstract][Full Text] [Related]
10. Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis.
De Decker K; Van Poucke S; Wojciechowski M; Ieven M; Colpaert C; Vogelaers D; Jorens PG
Pediatr Crit Care Med; 2006 Sep; 7(5):482-5. PubMed ID: 16878050
[TBL] [Abstract][Full Text] [Related]
11. Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.
Salas V; Pastor FJ; Calvo E; Sutton D; García-Hermoso D; Mayayo E; Dromer F; Fothergill A; Alvarez E; Guarro J
Med Mycol; 2012 Oct; 50(7):710-5. PubMed ID: 22458251
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with posaconazole in patients with invasive mucormycosis: a case series.
González-Ramos MM; Bertrán-Pasarell J; Guiot H; Soto R; Santana J; Amador R; Conde A
P R Health Sci J; 2008 Dec; 27(4):328-32. PubMed ID: 19069358
[TBL] [Abstract][Full Text] [Related]
13. Our 2014 approach to mucormycosis.
Tacke D; Koehler P; Markiefka B; Cornely OA
Mycoses; 2014 Sep; 57(9):519-24. PubMed ID: 24829170
[TBL] [Abstract][Full Text] [Related]
14. Case report of hepatic mucormycosis after liver transplantation: successful treatment with liposomal amphotericin B followed by posaconazole sequential therapy.
Abboud CS; Bergamasco MD; Baía CE; Lallée MP; Zan AS; Zamorano MM; Pereira OI; Mies S
Transplant Proc; 2012 Oct; 44(8):2501-2. PubMed ID: 23026630
[TBL] [Abstract][Full Text] [Related]
15. Part 2: mucormycosis: focus on therapy.
Lynch JP; Zhanel GG
Expert Rev Anti Infect Ther; 2023; 21(7):737-748. PubMed ID: 37300820
[TBL] [Abstract][Full Text] [Related]
16. Mucormycosis: New Developments into a Persistently Devastating Infection.
Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F
Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536
[TBL] [Abstract][Full Text] [Related]
17. Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin B.
Gebremariam T; Alkhazraji S; Gu Y; Najvar LK; Borroto-Esoda K; Patterson TF; Filler SG; Wiederhold NP; Ibrahim AS
Antimicrob Agents Chemother; 2024 May; 68(5):e0154523. PubMed ID: 38557112
[TBL] [Abstract][Full Text] [Related]
18. An Unusual Case of Pulmonary Mucormycosis.
Thomas S; Pawar B; Fernandes D; Nayar S; George P; Cherian S
Transplant Proc; 2018 Dec; 50(10):3943-3945. PubMed ID: 30503525
[TBL] [Abstract][Full Text] [Related]
19. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
Gebremariam T; Wiederhold NP; Alqarihi A; Uppuluri P; Azie N; Edwards JE; Ibrahim AS
J Antimicrob Chemother; 2017 Feb; 72(2):462-466. PubMed ID: 27798213
[TBL] [Abstract][Full Text] [Related]
20. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
Salmanton-García J; Seidel D; Koehler P; Mellinghoff SC; Herbrecht R; Klimko N; Ráčil Z; Falces-Romero I; Ingram P; Benítez-Peñuela MÁ; Rodríguez JY; Desoubeaux G; Barać A; García-Vidal C; Hoenigl M; Mehta SR; Cheng MP; Klyasova G; Heinz WJ; Iqbal N; Krause R; Ostermann H; Penack O; Schalk E; Sheppard DC; Willinger B; Wisplinghoff H; Vehreschild JJ; Cornely OA; Vehreschild MJGT;
J Antimicrob Chemother; 2019 Nov; 74(11):3315-3327. PubMed ID: 31393591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
